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     Abstract:  New alternative laboratory means are needed to improve the options for ante-25 
mortem diagnosis of avian aspergillosis. In this study, 3-hydroxybutyrate was measured in 
plasma samples collected from a cohort of African penguins (Spheniscus demersus) maintained 
under human care. Results were interpreted in combination with those of protein 
electrophoresis and compared to anti-Aspergillus antibody and galactomannan antigen 
detection. Overall, 3-hydroxybutyrate levels were found significantly increased in Aspergillus-30 
diseased cases versus control penguin groups (P=0.002). Mean absolute concentration of β-
globulins was increased >20% in samples from infected birds, and α2-globublins were also 
found to be significantly increased vs. control groups (P=0.001). Consequently, the 
combination of increased 3-hydroxybutyrate and increased α2-globulins did have a higher 
specificity than both markers alone (98.4% vs. 78.6% and 92.2%, respectively; P<0.05).  35 
Elevated 3-hydroxybutyrate levels combined with increases in α2-globulins or with any 
electrophoresis abnormalities reflected a high negative predictive value of 79.9% or 86.7%, 
respectively, vs. 64.7% when 3-hydroxybutyrate  was considered alone (P<0.05). In contrast, 
anti-Aspergillus antibody and galactomannan antigen did not distinguish between infected cases 
and controls (P>0.05). This study demonstrates that basic testing in tandem with the new 40 
biomarker 3-hydroxybutyrate may provide reliable evidence for the diagnosis of aspergillosis in 
penguins. 
 
     Key words: Aspergillus, aspergillosis, electrophoresis, penguin, hydroxybutyrate, diagnostic 
assay.  45 
  
3 
 
INTRODUCTION 
     Aspergillosis is a fungal airborne infection caused by ubiquitous molds of the Aspergillus 
genus. Aspergillosis can lead to fatal outcome both in diseased humans and animals, especially 
when the diagnosis is delayed and the antifungal therapy is inadequate.
19,23
 Some birds are 50 
known to be particularly susceptible to aspergillosis, including African penguins (Spheniscus 
demersus) which are maintained under human care in aquaria or during rehabilitation.
9
 
Unfortunately, avian aspergillosis remains difficult to diagnose as current laboratory 
diagnostics do not have consistent high sensitivity and specificity. In penguins, samples are 
often found negative for galactomannan antigen detection,
8
 while most have high levels of anti-55 
Aspergillus antibody reactivity regardless of clinical status.
7
 Biopsy sampling for fungal culture 
or histopathology can be difficult to perform in ill or debilitated patients. Furthermore, some 
medical imaging, e.g. celioscopy, is also not readily available in every facility, while 
radiography is often unreliable and rarely yields findings for aspergillosis in penguins.
7
  
   Veterinary practitioners currently depend on plasma protein electrophoresis (EPH) to address 60 
the diagnosis of aspergillosis and initiate preemptive antifungal treatment.
3,8
  Quantitation of 
serum proteins has been shown to provide a reflection of acute phase responses through the 
demonstration of change in albumin, a negative acute phase protein, and four globulin fractions 
which are often increased with different disease processes.
12
 The diagnostic and prognostic 
application of data obtained from commercial semi-automated methods of protein fractionation 65 
has been well described in veterinary medicine.
12,17
 Thus, plasma electrophoresis has become 
more widely utilized in avian medicine over the last 20 years.
2,4,5,20,25
 
     Proteomics and metabolomics are innovative tools that enable the ex vivo study of 
pathologic processes. Their use in research has previously defined possible new biomarkers of 
infection.
10,11
 Recently, a significant increase of some lipoproteins, fatty acids and ketone 70 
bodies including 3-hydroxybutyrate,
24 
was highlighted in falcons with Aspergillus fumigatus 
4 
 
versus healthy birds,
21
 through proton nuclear magnetic resonance spectroscopy and robust 
multivariate analysis. Elevation of 3-hydroxybutyrate is believed to indicate behavioral and/or 
metabolic adjustments directed to spare energy and body protein during infection.
8
 It indirectly 
reflects the need for activating fat mobilization.
1
 In experimental studies, it was demonstrated to 75 
increase in some vertebrate species especially in birds,
1,22
 but comprehensive clinical trials are 
lacking. In the present study, the diagnostic value of 3-hydroxybutyrate measurement in a 
cohort of blood samples from African penguins that were undergoing aspergillosis was assessed 
with comparison and in combination with EPH. 
  80 
MATERIALS AND METHODS 
Case definition.  The definitive diagnosis of “proven” or “probable” fungal infection had been 
assigned according to the classification derived from the definition utilized in human medicine.
9
 
“Proven” cases were based on histopathologic evidence (n=7) and “probable” cases had 
positive fungal cultures in conjunction with clinical signalment and corroborative imaging 85 
investigations (n=15). Penguins with clinical signs of aspergillosis, but with neither positive 
fungal cultures / histopathology evidences nor imaging findings available, were considered 
“possible” diagnosis (n=25)., if they responded to antifungal treatment.7  The control groups 
included penguins undergoing varied non-Aspergillus inflammatory diseases and clinically-
normal birds.  90 
The ages of the clinical groups were as follows: Aspergillus-diseased, 8.5 +/- 3.9 years; 
inflammatory controls, 23.8 +/- 4.0 years; clinically normal controls, 8.4 +/- 3.8 years. The 
percentages of male patients in each group were 69.6%, 56.3%, and 51.6%, respectively. 
Diagnostic testing.  Blood samples were drawn from penguin flipper vein, then heparinized in 
lithium tubes and centrifuged. If free from hemolysis and lipemia,
3–6
 plasma specimens were 95 
5 
 
refrigerated until analysis within 24 hours of submission to the laboratory.
10
 Otherwise, they 
were frozen at -80°C.  
Detection of anti-Aspergillus antibody was conducted via a previously described ELISA 
technique using bulk Aspergillus ID antigens made of pooled mycelial-phase culture filtrates of 
Aspergillus species (IMMY, Norman, OK, 73071, U.S.A.).
7
 Galactomannan antigen was 100 
measured in blood according to the manufacturers’ recommendations (Bio-Rad Clinical 
Diagnostics, Hercules, CA, 94547, U.S.A.).
3,7,8,13 
 
EPH results were obtained from the SPIFE 3000
®
 electrophoresis analyzer (Helena Labs, 
Beaumont, TX, 77707, U.S.A.).
5
 They were subcategorized as abnormal on the basis of at least 
a 10%-change (in absolute concentration) compared to the reference intervals of at least one 105 
protein fraction. 
3-hydroxybutyrate measurement analysis was conducted using the RX Daytona+
®
 instrument 
with Randox
®
 reagents (Randox Laboratories, Kearneysville, WV, 25430, U.S.A.).  
Statistical analysis.  Methods validation was conducted according to prior recommendations.
15
 
Statistical analysis was completed by using XLStat Premium v.18.07
®
 software (Addinsoft, 110 
Paris, France).  The P-values were obtained by the non-parametric Kruskal-Wallis test used 
herein for comparing three independent groups of different sample sizes. The guidelines of 
American Society for Veterinary Clinical Pathology for publication of clinical pathology data 
were followed.
14
 Reference intervals (RI) were calculated using MedCalc v.16.4.3 (MedCalc 
software, 8400 Ostend, Belgium) according to parametric double-sided method for normal 115 
distribution with 90% confidence intervals. 
 
RESULTS 
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Clinical group definition Characteristics of included penguins are listed in Table 1. Overall, 
172 blood samples were collected from naturally-infected cases (n1=47) and from control 120 
penguins with inflammatory disease (n2=29, inclusive of chronic arthritis, mild viral bronchitis, 
malaria, chronic anemia, and metastatic adenocarcinoma) or clinically-normal status (n3=96, as 
reported by submitting institutions). 
     Clinical suspicion of aspergillosis was very strong in most diseased cases: 67.6% showed 
respiratory signs (e.g. dyspnea, wheezing, gasping, stridor, open-mouth breathing, coughing, 125 
changes in vocalizations), 11.8% neurological signs (e.g. ataxia, opistophonos, torticollis, limb 
paresis, blindness, behavioural changes), and 76.5% general signs (e.g. lethargy, anorexia, 
weight loss, lack of appetite, sternal recumbency, regurgitation).  
 Antibody and antigen detection.  The level of reactivity for anti-Aspergillus antibody was not 
different between the Aspergillus-diseased cases and the control groups (P=0.76): 92.3% 130 
69.2%, and 79.2%, samples expressed positive reactivity with an index ≥1.4 among 
Aspergillus-diseased, non-Aspergillus inflammatory control and clinically-normal penguins, 
respectively.  
     There were also no significant differences between the penguin groups for the mean measure 
of galactomannan antigen (P=0.14, Table 1). For example, 23.1% Aspergillus-diseased birds 135 
had an antigen an index ≥0.7, whereas 37.5% non-Aspergillus inflammatory controls had index 
≥0.7. 
Plasma protein electrophoresis. The albumin/globulin (A/G) ratio, prealbumin concentration, 
and α1-globulins were found to be significantly lower in the Aspergillus-diseased cases vs. 
clinically-normal penguins (P<0.005). In contrast, α2, β, and γ-globulins were significantly 140 
increased in Aspergillus-diseased birds vs. clinically-normal penguins (P<0.005) (Table 1). 
Notably, respective mean concentrations for the Aspergillus-diseased cases were not different 
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from those for the non-Aspergillus inflammatory controls, except for α2-globulins (1.13 g/dL ± 
0.27 vs. 0.86 g/dL± 0.20, P<0.05). A typical EPH pattern for a clinically normal penguin and a 
penguin with aspergillosis is shown in Figure 1. 145 
     Overall, significant changes were observed for A/G ratio in 66.7% and 58.6%, for pre-
albumin in 25.6% and 36.4%, for albumin in 58.5% and 34.6%, for α1-globulins in 7.3% and 
13.6%, for α2-globulins in 45.2% and 18.2%, for β-globulins in 57.1% and 48.1%, and for γ-
globulins in 36.6% and 32.1% of samples from Aspergillus-diseased cases and non-Aspergillus 
inflammatory controls, respectively. β-globulins reflected the largest increases in Aspergillus-150 
diseased penguins (+20.4% compared to upper normal limit). EPH specificity to Aspergillus-
disease was determined at 57.3% [CI 49.4 to 64.6] and 74.5% [CI 66.9 to 80.5], when 1 and 
2 protein fraction(s) showed >10% significant change from normal ranges, respectively. 
However, elevated α2-globulins demonstrated high specificity to aspergillosis at 92.2% [CI 
86.0 to 95.3], when positive cutoff was set at 1.0 g/dL (but sensitivity was only 45.2% [CI 33.6 155 
to 57.7]), and the positive (PPV) and negative predictive values (NVP) were at 70.4% [CI 55.9 
to 84.8%] and 80.5% [CI 74.5 to 86.5%], respectively. 
3-hydroxybutyrate measurement.  The mean concentration of 3-hydroxybutyrate in penguin 
plasma was 1.33 mmol/L ± 0.59 in Aspergillus-diseased cases (Table 1). It was significantly 
higher than that observed in the two control groups, i.e. 0.94 mmol/L ± 0.13 and 0.77 mmol/L ± 160 
0.22 for the clinically-normal and the non-Aspergillus inflammatory penguins, respectively 
(P=0.002) (Figure 2).  
     Receiving operator characteristic (ROC) curve established the lower positive cutoff at 0.60 
mmol/L, but the specificity was not satisfactory (53.6%, [CI 35.8 to 70.4]), in spite of high 
sensitivity (91.2%, [CI 77.8 to 95.9]). Thus, the upper positive cutoff was set at 0.94 mmol/L 165 
(sensitivity: 64.7%, [CI 50.3 to76.0]; specificity: 78.6%, [CI 71.2 to 84.0]) (Table 2). 
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Diagnostic performance of combined tests.  With the lower cutoff of 3-hydroxybutyrate (0.60 
mmol/L) and at least one significant change >10% for any protein fraction in EPH, sensitivity 
and specificity of the combined test were assessed at 64.5% [CI 49.4 to 76.3] and 73.5% [CI 
65.3 to 78.8], respectively. The NPV was high, e.g. 86.7%, [CI 80.1 to 92.9]. When the upper 170 
cutoff of 0.94 mmol/L was used with at least one significant change >10% for any protein 
fraction in EPH, the sensitivity and specificity were at 38.7% [CI 26.4 to 53.6] and 86.9% [CI 
79.7 to 91.2].  The upper 3-hydroxybutyrate cutoff combined with α2-globulins absolute 
concentration (with positive threshold at 1.0 g/dl), provided excellent overall specificity, i.e. 
98.4% [CI 94.4 to 99.4], while NPV and PPV were both elevated at 79.9 % [CI 72.9 to 85.2] 175 
and 77.8 % [CI 55.0 to 1.00], respectively. 
    
DISCUSSION 
     As with other animal species and humans, diagnosis of aspergillosis in birds remains 
difficult.
4–6
 Ante-mortem diagnostics display poor performance. As demonstrated in this study, 180 
serological assays are often not able to distinguish between controls and Aspergillus-diseased 
cases. In the current assay, the mean indices for anti-Aspergillus antibody detection were 
similar to those observed in 108 other penguins in a prior study.
7  
 
     In contrast to psittacine electrophoretograms where β-globulins are the dominant globulin 
fraction in clinically-normal birds, the electrophoretogram of the penguin demonstrates a 185 
significant level of protein in the α2-, as well as in β-globulins, and is a reflection of an increase 
in a myriad of positive acute phase proteins (Figure 1).
4,12,17
 The significant change in α2-
globulins in Aspergillus-diseased penguins is interesting and may reflect an increase in 
haptoglobin which may reflect a chronic inflammatory process (C. Cray, personal observation). 
Changes in -globulins would be consistent with the stimulation of humoral immunity. The 1-190 
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fraction remains poorly defined regardless of clinical condition.  A prealbumin fraction is 
present as a shoulder migrating to the left of the albumin fraction. The clinical significance of 
prealbumin in birds is not been defined; however, prealbumin has been observed to decrease in 
falcons with naturally-acquired and experimentally-induced aspergillosis.
18,26
 In clinically-
abnormal penguins, a moderate decrease in percent albumin is often present; this is supportive 195 
of its designation as a negative acute phase protein. Importantly, EPH has been demonstrated to 
be the only valid method (vs. bromocresol green methods) for albumin quantitation.
6
  
     Plasma changes in 3-hydroxybutyrate concentration were hypothesized to have diagnostic 
relevance upon observation of increased concentration in experimentally-infected falcons.
21
 Its 
elevation was assumed to reflect the need for energy activating during the infection.
1
  200 
In the current study, it was statistically determined in a cohort of Aspergillus-diseased penguins, 
with an elevated mean measurement at 1.33 mmol/L ± 0.59. Notably, a special caution should 
be raised to the wide confidence interval of the results, suggesting important inter-individual 
variations, and to the age difference with penguins undergoing non-aspergillosis inflammatory 
(the potential effects that age could play in the interpretation of results have not been clearly 205 
demonstrated). Anyway, in nine penguins with history of resolved Aspergillus-infection 
(diagnosis established 68 days ± 14 earlier; 100.0% recovered when treated with antifungal 
drugs), the mean concentration for 3-hydroxybutyrate was low (0.86 mmol/L ± 0.10). In 
contrast, a high value of 6.00 mmol/L was reported in a severely infected penguin three days 
prior its death. Overall, concentrations >1.90 mmol/L were observed in penguins at the apparent 210 
peak of the Aspergillus-disease with significant clinical signs including hyper inflated cervical 
air sacs, coughing, wheezing and stridor, and strongly suggestive radiographic findings. These 
findings suggest a possible prognostic value of 3-hydroxybutyrate concentration, as levels 
return to normal when penguins recover in contrast to very elevated levels when clinical signs 
of aspergillosis are severe. However, 3-hydroxybutyrate levels have been also studied in finches 215 
10 
 
adapting to winter conditions compared to levels measured in the summer: it was found to 
increase in fasting birds as well as in birds adapted to winter conditions, though stayed 
relatively static in fed birds in both summer and winter.
2
 This suggests that the variations of 3-
hydroxybutyrate may be also strongly linked to fasting and overall nutritional status/energy 
balance. So in order to improve its diagnostic performance, its measurement in blood perhaps 220 
requires concomitant additional analysis like comparison in tandem with EPH results. Indeed, 
combined tests are assumed to be theoretically able to overcome specificity limitations. 
Because EPH and 3-hydroxybutyrate assessment are two distinct tests, they have independent 
false-positive and false-negative rates that are unlikely to occur in the same study cases. The 
results showed that if both EPH fractions and 3-hydroxybutyrate levels were normal, the 225 
probability appeared high that the penguin was not infected with Aspergillus with NPV 
calculated at 86.7%. Furthermore, α2-globulins demonstrated high specificity to aspergillosis at 
92.2%, and it is the reason why its combination with the upper 3-hydroxybutyrate cutoff offered 
very elevated specificity at 98.4%. 
     In conclusion, this brief report underscores the potential utility of 3-hydroxybutyrate 230 
measurement for the initial diagnosis of aspergillosis in penguins especially when combined 
with routine testing like EPH.  Further studies are warranted in order to confirm the diagnostic 
and prognostic benefits of 3-hydroxybutyrate in other penguin and avian species. For instance, 
it may be relevant to compare its measurements in subjects with well-controlled food intake to 
assert that its increases were not only due to these birds not eating because of severe infection.  235 
 
     Acknowledgements:  This project was supported by the African penguin Species Survival 
Plan (SSP) as part of the Association of Zoos & Aquariums (AZA) Saving Animals From 
Extinction (SAFE) conservation initiative. 
11 
 
     Thank you to the institutions that enrolled their patients: California Academy of Sciences 240 
(San Francisco, CA, U.S.A.), Minnesota Zoo (Apple Valley, MN, U.S.A.), Busch Gardens 
Tampa (Tampa, FL, U.S.A.),The Maryland Zoo in Baltimore (Baltimore, MD, U.S.A.), Tulsa 
Zoo& Living Museum (Tulsa, OK, U.S.A.), Fort Wayne Children’s Zoo (Fort Wayne, IN, 
U.S.A.), Georgia Aquarium (Atlanta, GA, U.S.A.), Sea Research Foundation, Inc. d/b/a Mystic 
Aquarium (Mystic, CT, U.S.A.), and Cincinnati Zoo and Botanical Garden (Cincinnati, OH, 245 
U.S.A.). 
   
  
12 
 
LITERATURE CITED 
 1. Albano N, Masero JA, Villegas A, Abad-Gómez JM, Sánchez-Guzmán JM. Plasma 250 
metabolite levels predict bird growth rates: a field test of model predictive ability. Comp 
Biochem Physiol A Mol Integr Physiol. 2011;160(1):9–15.  
 2. Bech C, Eidsmo Reinertsen R. Physiology of cold adaptation in birds [Internet]. 
Softcover reprint of the original 1st ed. 1989 (16 avril 2013). Springer-Verlag New York Inc.; 
1989 [cited 2018 Jan 3]. 384 p. Available from: //www.springer.com/gp/book/9780306432378 255 
 3. Cray C, Arcia G, Schneider R, Kelleher SA, Arheart KL. Evaluation of the usefulness 
of an ELISA and protein electrophoresis in the diagnosis of Encephalitozoon cuniculi infection 
in rabbits. Am J Vet Res. 2009;70(4):478–482.  
 4. Cray C, Reavill D, Romagnano A, Van Sant F, Champagne D, Stevenson R, Rolfe V, 
Griffin C, Clubb S. Galactomannan assay and plasma protein electrophoresis findings in 260 
psittacine birds with aspergillosis. J Avian Med Surg. 2009;23(2):125–135.  
 5. Cray C, Watson T, Arheart KL. Serosurvey and diagnostic application of antibody 
titers to Aspergillus in avian species. Avian Dis. 2009;53(4):491–494.  
 6. Cray C, Watson T, Rodriguez M, Arheart KL. Application of galactomannan analysis 
and protein electrophoresis in the diagnosis of aspergillosis in avian species. J Zoo Wildl Med. 265 
2009;40(1):64–70.  
 7. Jones MP, Orosz SE. The diagnosis of aspergillosis in birds. Semin Avian Exot Pet 
Med. 2000;9(2):52–58.  
13 
 
 8. Robin JP, Boucontet L, Chillet P, Groscolas R. Behavioral changes in fasting emperor 
penguins: evidence for a “refeeding signal” linked to a metabolic shift. Am J Physiol. 270 
1998;274(3 Pt 2):R746-753.  
 9. Seyedmousavi S, Guillot J, Arné P, de Hoog GS, Mouton JW, Melchers WJG, 
Verweij PE. Aspergillus and aspergilloses in wild and domestic animals: a global health 
concern with parallels to human disease. Med Mycol. 2015;53(8):765–797.  
 10. Vap LM, Harr KE, Arnold JE, Freeman KP, Getzy K, Lester S, Friedrichs KR, 275 
American Society for Veterinary Clinical Pathology (ASVCP). ASVCP quality assurance 
guidelines: control of preanalytical and analytical factors for hematology for mammalian and 
nonmammalian species, hemostasis, and crossmatching in veterinary laboratories. Vet Clin 
Pathol. 2012;41(1):8–17.  
 280 
14 
 
FIGURE LEGENDS 
     Figure 1:  Typical electrophoretograms of a clinically normal (A) and Aspergillus-diseased 
African penguin (B).  The fractions, from left to right, are prealbumin, albumin, α1-, α2-, β-, 
and γ-globulins.          
 285 
     Figure 2:  Boxplots showing distribution of 3-hydroxybutyrate measurement in samples 
collected from Aspergillus-diseased penguins (dark grey, n=47) and from control penguins 
undergoing miscellaneous non-Aspergillus inflammatory processes (light grey, n=29).  
 
